(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ALLERGAN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ALLERGAN

ST13

US500000078952383

Class

5, 10, 41, 44

Filing

78952383

Registration

3596709

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

51

Latest update

04/26/2019

Trademark type

Word

Nice classes

5, 10, 41, 44

Filing date

08/15/2006

Registration date

03/24/2009

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/26/2019

Last transaction

04/26/2019

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

09/30/1990

First use in commerce

01/22/1992

Drawing code

4

Owner type

03

Owner location

Irvine, CA, US

Examiner

ESTRADA,LINDA M

Law office

L40

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Allergan, Inc.

Representatives

Annie Chen Allergan, Inc.

Technical classification

Nice Classes

Class 5Class 10Class 41Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

House mark used for a line of pharmaceuticals used in connection with anti-agingthe treatment of glabellar linesfacial wrinklesasymmetries and defects and conditions of the human skinfacial aesthetic surgeryfacial aesthetic reconstructionbreast aesthetics and anti-obesity

Class 10

House mark used for a line of medical devices used in connection with anti-agingthe treatment of glabellar linesfacial wrinklesasymmetries and defects and conditions of the human skinfacial aesthetic surgeryfacial aesthetic reconstructionbreast aesthetics and anti-obesity

Class 41

Patient education servicesclassesseminars and workshops in the fields of breast aesthetic and reconstructionfacial aesthetic and anti-obesity surgery

Class 44

Medical informational services in the field of breast aesthetic and reconstructionfacial aesthetic and anti-obesity surgery

Publications

History of USPTO decisions and trademark events.

51 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

04/26/2019

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

04/26/2019

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

04/26/2019

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/26/2019

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/25/2019

E89R

TEAS SECTION 8 & 9 RECEIVED

03/25/2019

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

03/24/2018

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

10/29/2014

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

10/29/2014

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/29/2014

E815

TEAS SECTION 8 & 15 RECEIVED

10/20/2014

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/20/2014

R.PR

REGISTERED-PRINCIPAL REGISTER

03/24/2009

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

02/17/2009

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

02/14/2009

XAEC

EXAMINER'S AMENDMENT ENTERED

01/29/2009

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

01/27/2009

GNEA

EXAMINERS AMENDMENT E-MAILED

01/27/2009

SNEA

SU-EXAMINER'S AMENDMENT WRITTEN

01/27/2009

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

10/08/2008

GNFR

FINAL REFUSAL E-MAILED

10/08/2008

CNFR

SU - FINAL REFUSAL - WRITTEN

10/08/2008

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/16/2008

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/16/2008

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/16/2008

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/03/2008

GNRT

NON-FINAL ACTION E-MAILED

04/03/2008

CNRT

SU - NON-FINAL ACTION - WRITTEN

04/03/2008

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

04/03/2008

ISER

WITHDRAWN FROM ISSUE - EXAMINING ATTORNEY REQUEST

03/31/2008

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

03/20/2008

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

03/19/2008

SUPC

STATEMENT OF USE PROCESSING COMPLETE

02/26/2008

EX1G

SOU EXTENSION 1 GRANTED

02/26/2008

EEXT

SOU TEAS EXTENSION RECEIVED

01/31/2008

EISU

TEAS STATEMENT OF USE RECEIVED

01/31/2008

IUAF

USE AMENDMENT FILED

01/30/2008

EXT1

SOU EXTENSION 1 FILED

01/30/2008

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

08/14/2007

PUBO

PUBLISHED FOR OPPOSITION

05/22/2007

NPUB

NOTICE OF PUBLICATION

05/02/2007

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

03/23/2007

ALIE

ASSIGNED TO LIE

03/23/2007

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/27/2007

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/06/2007

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/05/2007

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/05/2007

GNRT

NON-FINAL ACTION E-MAILED

12/14/2006

CNRT

NON-FINAL ACTION WRITTEN

12/14/2006

DOCK

ASSIGNED TO EXAMINER

12/07/2006

NWAP

NEW APPLICATION ENTERED

08/18/2006

Continuous trademark protection

Get notified about every new filing that threatens ALLERGAN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.